GlassScriptPhysician profile
Danielle Sheree Kiko
NPI 1417161563
$400.26
in general payments reported to CMS, 2019-2025
13 companies · $60.04 in 2025
The $60.04 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $88.26 · 2020: $15.71 · 2022: $107 · 2023: $74.05 · 2024: $55.11 · 2025: $60.04.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $189.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $189.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $57.53 | 2022 | |
| Axonics, INC. | $50.10 | 2023-2024 | Axonics, Bulkamid |
| Abbvie INC. | $49.56 | 2022 | |
| Mayne Pharma Commercial LLC | $46.96 | 2023-2025 | |
| Astellas Pharma US INC | $45.62 | 2023-2024 | Veozah |
| Boston Scientific Corporation | $28.98 | 2025 | Axonics |
| Avion Pharmaceuticals | $28.74 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.67 | 2019 | |
| Sage Therapeutics, LLC | $17.54 | 2024 | |
| Novum Pharma, LLC | $15.36 | 2019 | |
| Therapeuticsmd, INC. | $14.38 | 2019 | |
| Allergan, INC. | $14.13 | 2019 | |
| Duchesnay USA Incorporated | $13.69 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Kiko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.